Maurizio Chiriva- Internati

Maurizio Chiriva- Internati

Company: Kiromic Biopharma

Job title: CEO & President


Bioinformatics to Identify Optimal Solid Tumor Targets and Improve Antigen Selection 3:00 pm

Discuss what is the CD19 equivalent in solid tumors? Review the clinical potential of HER2, MAC3, MAC4, Mage3, Mage4, and more Best-in-class bioinformatics platforms to identify safe tumor targetsRead more

day: Day One

Determine Optimal Cells for Tumor Infiltration 10:10 am

Analyse the differentiation state most optimal to effectively infiltrate tumors Examine the chemokines produced by tumors to recruit immune cells, outlining which cell types have the best chance of recruitment Consider the potential of macrophages with their inherent ability to traffic and thrive in the TMERead more

day: Bootcamp Day

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.